Puma Biotech (PBYI), Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China
Go back to Puma Biotech (PBYI), Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 9.62 +0.02 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.60 | 52 Week High | $82.81 | |||
| Open | $9.66 | 52 Week Low | $19.74 | |||
| Day High | $9.75 | P/E | N/A | |||
| Day Low | $9.55 | EPS | $-2.16 | |||
| Volume | 67,639 | |||||
